First Horizon Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

First Horizon Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-853	Closed	-$15K	–	1615
2018 Q1	$15K	Hold	853	–	–	﹤0.01%	886
2017 Q4	$14K	Buy	853 +433	+103%	+$7.94K	﹤0.01%	944
2017 Q3	$9K	Hold	420	–	–	﹤0.01%	1047
2017 Q2	$6K	Hold	420	–	–	﹤0.01%	1139
2017 Q1	$5K	Hold	420	–	–	﹤0.01%	1223
2016 Q4	$9K	Hold	420	–	–	﹤0.01%	1041
2016 Q3	$9K	Hold	420	–	–	﹤0.01%	1032
2016 Q2	$12K	Hold	420	–	–	﹤0.01%	918
2016 Q1	$12K	Buy	+420	New	+$14.8K	﹤0.01%	953
2014 Q4	–	Sell	-50	Closed	-$1K	–	1603
2014 Q3	$1K	Hold	50	–	–	﹤0.01%	1443
2014 Q2	$1K	Buy	+50	New	+$1.35K	﹤0.01%	1437

First Horizon Advisors's IPXL Position: Q2 2018 in Review

First Horizon Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 853 shares — an estimated $15K sold.

First Horizon Advisors first reported a position in IPXL in Q2 2014 and held it in 11 quarters. The position peaked at $15K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

First Horizon Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
First Horizon Advisors sold 853 Impax Laboratories, Inc. shares in Q2 2018, an estimated $15K.
First Horizon Advisors first reported a position in Impax Laboratories, Inc. in Q2 2014 and held it in 11 quarters.
First Horizon Advisors's Impax Laboratories, Inc. position peaked at $15K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on First Horizon Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.